Cargando…

P32 Performance of a novel molecular test designed for point-of-care UTI diagnosis

OBJECTIVES: To evaluate the performance of a novel LAMP-based molecular test for the diagnosis of UTIs. The Llusern Scientific UTI test system consists of a panel of six uropathogen tests, positive and negative controls and an analyser, ‘Lodestar DX’ (Figure 1). The analyser will read the reaction d...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Goes, Ayako, Diggle, Joanna, Nieuwland, Jeroen, Roula, Ali, Hayhurst, Emma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395438/
http://dx.doi.org/10.1093/jacamr/dlad077.036
_version_ 1785083576563269632
author van der Goes, Ayako
Diggle, Joanna
Nieuwland, Jeroen
Roula, Ali
Hayhurst, Emma
author_facet van der Goes, Ayako
Diggle, Joanna
Nieuwland, Jeroen
Roula, Ali
Hayhurst, Emma
author_sort van der Goes, Ayako
collection PubMed
description OBJECTIVES: To evaluate the performance of a novel LAMP-based molecular test for the diagnosis of UTIs. The Llusern Scientific UTI test system consists of a panel of six uropathogen tests, positive and negative controls and an analyser, ‘Lodestar DX’ (Figure 1). The analyser will read the reaction data and give the user a simple ‘positive’ or ‘negative’ read out for each uropathogen. The specific aim was to determine the sensitivity and specificity of the test system for the most common uropathogen, Escherichia coli. [Figure: see text] METHODS: In total, 149 urine samples received by Public Health Wales laboratories, Cardiff were randomly selected; 1 μL of each urine sample was added directly to each pre-made E. coli LAMP test. E. coli LAMP tests were placed into the Lodestar DX analyser and run. Results were shown and recorded after 40 minutes as ‘positive’ or ‘negative’ according to the decision of Lodestar's algorithm. LAMP results were compared to standard culture results and sensitivity and specificity calculated. RESULTS: Overall sensitivity of the E. coli LAMP test was 86.2%. Specificity was 88.3% (Table 1). Of the 14 samples positive in the LAMP test for E. coli but not recorded as E. coli using culture, 11 were from ‘mixed growth’ samples (Table 2). [Table: see text]   [Table: see text] CONCLUSIONS: The Llusern Scientific UTI test system shows great promise as a point-of-care diagnostic tool. Sensitivity and specificity for E. coli was high and the test system may be better at diagnosing mixed infections which represent a high proportion of all culture results. The test system is easy to use with no sample processing and minimal training requirements. Test results are available in 40 min, compared to 24–72 h for culture results. The performance of the test system for the detection of other uropathogens (Klebsiella, Enterococcus, Pseudomonas, Proteus and S. saprophyticus) is ongoing. Sensitivity can be further improved by refining the test method.
format Online
Article
Text
id pubmed-10395438
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-103954382023-08-03 P32 Performance of a novel molecular test designed for point-of-care UTI diagnosis van der Goes, Ayako Diggle, Joanna Nieuwland, Jeroen Roula, Ali Hayhurst, Emma JAC Antimicrob Resist Abstracts OBJECTIVES: To evaluate the performance of a novel LAMP-based molecular test for the diagnosis of UTIs. The Llusern Scientific UTI test system consists of a panel of six uropathogen tests, positive and negative controls and an analyser, ‘Lodestar DX’ (Figure 1). The analyser will read the reaction data and give the user a simple ‘positive’ or ‘negative’ read out for each uropathogen. The specific aim was to determine the sensitivity and specificity of the test system for the most common uropathogen, Escherichia coli. [Figure: see text] METHODS: In total, 149 urine samples received by Public Health Wales laboratories, Cardiff were randomly selected; 1 μL of each urine sample was added directly to each pre-made E. coli LAMP test. E. coli LAMP tests were placed into the Lodestar DX analyser and run. Results were shown and recorded after 40 minutes as ‘positive’ or ‘negative’ according to the decision of Lodestar's algorithm. LAMP results were compared to standard culture results and sensitivity and specificity calculated. RESULTS: Overall sensitivity of the E. coli LAMP test was 86.2%. Specificity was 88.3% (Table 1). Of the 14 samples positive in the LAMP test for E. coli but not recorded as E. coli using culture, 11 were from ‘mixed growth’ samples (Table 2). [Table: see text]   [Table: see text] CONCLUSIONS: The Llusern Scientific UTI test system shows great promise as a point-of-care diagnostic tool. Sensitivity and specificity for E. coli was high and the test system may be better at diagnosing mixed infections which represent a high proportion of all culture results. The test system is easy to use with no sample processing and minimal training requirements. Test results are available in 40 min, compared to 24–72 h for culture results. The performance of the test system for the detection of other uropathogens (Klebsiella, Enterococcus, Pseudomonas, Proteus and S. saprophyticus) is ongoing. Sensitivity can be further improved by refining the test method. Oxford University Press 2023-08-02 /pmc/articles/PMC10395438/ http://dx.doi.org/10.1093/jacamr/dlad077.036 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
van der Goes, Ayako
Diggle, Joanna
Nieuwland, Jeroen
Roula, Ali
Hayhurst, Emma
P32 Performance of a novel molecular test designed for point-of-care UTI diagnosis
title P32 Performance of a novel molecular test designed for point-of-care UTI diagnosis
title_full P32 Performance of a novel molecular test designed for point-of-care UTI diagnosis
title_fullStr P32 Performance of a novel molecular test designed for point-of-care UTI diagnosis
title_full_unstemmed P32 Performance of a novel molecular test designed for point-of-care UTI diagnosis
title_short P32 Performance of a novel molecular test designed for point-of-care UTI diagnosis
title_sort p32 performance of a novel molecular test designed for point-of-care uti diagnosis
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395438/
http://dx.doi.org/10.1093/jacamr/dlad077.036
work_keys_str_mv AT vandergoesayako p32performanceofanovelmoleculartestdesignedforpointofcareutidiagnosis
AT digglejoanna p32performanceofanovelmoleculartestdesignedforpointofcareutidiagnosis
AT nieuwlandjeroen p32performanceofanovelmoleculartestdesignedforpointofcareutidiagnosis
AT roulaali p32performanceofanovelmoleculartestdesignedforpointofcareutidiagnosis
AT hayhurstemma p32performanceofanovelmoleculartestdesignedforpointofcareutidiagnosis